Blincyto


Infusion
scheduling status
S4
registration number
54/26/0736
What Blincyto contains
blinatumomab.
other ingredients
Powder: Citric acid monohydrate Trehalose dihydrate Lysine hydrochloride Polysorbate 80 Sodium hydroxide IV solution stabiliser: Citric acid monohydrate Lysine hydrochloride Polysorbate 80 Sodium hydroxide Water for injection.
Therapeutic classification
Antineoplastic agents (L01) L01FX.
© 2026 SAHPRA. ALL RIGHTS RESERVED